A Rejthar

905 total citations
32 papers, 789 citations indexed

About

A Rejthar is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, A Rejthar has authored 32 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in A Rejthar's work include Skin and Cellular Biology Research (6 papers), Immunotherapy and Immune Responses (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). A Rejthar is often cited by papers focused on Skin and Cellular Biology Research (6 papers), Immunotherapy and Immune Responses (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). A Rejthar collaborates with scholars based in Czechia, Russia and United Kingdom. A Rejthar's co-authors include Jan Kovařík, Jiřina Bártková, Bořivoj Vojtěšek, Z Stasková, Jiří Lukáš, David P. Lane, Julian Gannon, Jiří Bártek, Jiří Bártek and Zdeněk Lukáš and has published in prestigious journals such as British Journal of Cancer, Journal of Clinical Pathology and Histochemistry and Cell Biology.

In The Last Decade

A Rejthar

29 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Rejthar Czechia 8 421 305 120 116 104 32 789
M Furihata Japan 19 401 1.0× 526 1.7× 74 0.6× 161 1.4× 89 0.9× 39 1.0k
J W Shay Japan 9 454 1.1× 577 1.9× 61 0.5× 123 1.1× 52 0.5× 10 1.3k
Aleš Rejthar Czechia 8 324 0.8× 184 0.6× 47 0.4× 131 1.1× 80 0.8× 11 528
Takenori Ishikawa Japan 17 383 0.9× 499 1.6× 99 0.8× 143 1.2× 120 1.2× 52 1.1k
Jeannine Lacroix Germany 15 490 1.2× 253 0.8× 56 0.5× 186 1.6× 103 1.0× 25 826
P. Crotty Ireland 8 320 0.8× 466 1.5× 54 0.5× 97 0.8× 50 0.5× 15 861
Concetta Chiarelli Italy 11 308 0.7× 246 0.8× 58 0.5× 79 0.7× 135 1.3× 16 839
D Bautista Canada 7 268 0.6× 600 2.0× 34 0.3× 111 1.0× 41 0.4× 8 1.0k
Daniel R. Vlock United States 17 447 1.1× 332 1.1× 33 0.3× 163 1.4× 64 0.6× 32 916
D. N. Carney United States 13 375 0.9× 339 1.1× 125 1.0× 86 0.7× 35 0.3× 26 709

Countries citing papers authored by A Rejthar

Since Specialization
Citations

This map shows the geographic impact of A Rejthar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rejthar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rejthar more than expected).

Fields of papers citing papers by A Rejthar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Rejthar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rejthar. The network helps show where A Rejthar may publish in the future.

Co-authorship network of co-authors of A Rejthar

This figure shows the co-authorship network connecting the top 25 collaborators of A Rejthar. A scholar is included among the top collaborators of A Rejthar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Rejthar. A Rejthar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rejthar, A & Rudolf Nenutil. (1997). The intermediate filaments and prognostically oriented morphological classification in ductal breast carcinoma.. PubMed. 44(6). 370–3. 5 indexed citations
2.
Nenutil, Rudolf, et al.. (1997). DNA flow cytometry: a predictor of a high-risk group in cervical cancer.. PubMed. 21(3). 242–6. 7 indexed citations
3.
Lang, Bianca, et al.. (1997). Phylloid breast tumors and three steroid hormone receptors.. PubMed. 44(1). 53–7. 2 indexed citations
4.
Vojtěšek, Bořivoj, Jan Kovařík, Rudolf Nenutil, et al.. (1995). p53 protein overexpression associates with growth patterns rather than with metastasizing in operable breast cancer.. PubMed. 42(6). 331–6.
5.
Pecen, Ladislav, et al.. (1994). Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development.. PubMed. 41(5). 245–52. 5 indexed citations
6.
Lauerová, L, et al.. (1992). Fusion-induced malignancy? A preliminary study. (a challenge to today's common wisdom).. PubMed. 39(2). 79–86. 8 indexed citations
7.
Rejthar, A, et al.. (1991). Do some malignant melanoma cells share antigens with the myeloid monocyte lineage?. PubMed. 38(4). 401–5. 5 indexed citations
8.
Bártek, Jiří, Jiřina Bártková, Bořivoj Vojtěšek, et al.. (1991). Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.. PubMed. 6(9). 1699–703. 452 indexed citations
9.
Bártková, Jiřina, Jiří Bártek, Zdeněk Lukáš, et al.. (1991). Effects of tissue fixation conditions and protease pretreatment on immunohistochemical performance of a large series of new anti-keratin monoclonal antibodies: value in oncopathology.. PubMed. 38(4). 439–46. 4 indexed citations
10.
Vojtěšek, Bořivoj, Z Stasková, Rudolf Nenutil, et al.. (1990). A panel of monoclonal antibodies to keratin no. 7: characterization and value in tumor diagnosis.. PubMed. 37(3). 333–42. 9 indexed citations
11.
Bártek, Jiří, Helena Tlaskalová‐Hogenová, Z Stasková, et al.. (1989). Secretory component in differentiating normal epithelium, benign lesions and malignancy in the human breast as monitored by monoclonal antibodies. Histochemistry and Cell Biology. 91(3). 235–244. 6 indexed citations
12.
Rejthar, A, et al.. (1989). Phenotypic variability of chemically induced primary rat mammary tumors.. PubMed. 36(1). 103–12. 2 indexed citations
13.
Rejthar, A, et al.. (1987). Differentiation Patterns of Testicular Germ-Cell Tumours as Revealed by a Panel of Monoclonal Antibodies. Tumor Biology. 8(1). 45–56. 4 indexed citations
14.
Bártek, Jiří, et al.. (1987). HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours. British Journal of Cancer. 56(6). 727–733. 24 indexed citations
15.
Svoboda, Jan, et al.. (1985). Isolation of two transforming viruses from sarcomas obtained in chickens inoculated intraembryonally with a transformation defective mutant of Prague strain Rous sarcoma virus.. PubMed. 31(2). 135–51. 5 indexed citations
16.
Kovařík, Jan, J Bártek, A Rejthar, Jiřina Bártková, & L Lauerová. (1985). Development, characterization and clinical applications of a new anti-keratin monoclonal antibody. European Journal of Cancer and Clinical Oncology. 21(11). 1396–1396. 3 indexed citations
17.
Kovařík, Jan, et al.. (1978). Establishment of cell line derived from human malignant melanoma.. PubMed. 25(6). 701–12. 2 indexed citations
18.
Rejthar, A, et al.. (1978). Prognostic significance of an enhanced number of T lymphocytes in chronic lymphatic leukemia.. PubMed. 25(1). 141–4. 1 indexed citations
19.
Rejthar, A, et al.. (1974). Difference in density of nuclear pores in normal and malignant fibroblasts of Syrian hamster.. PubMed. 21(4). 479–82. 5 indexed citations
20.
Rejthar, A, et al.. (1973). Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. II. Search for a common antigen in some organs and spontaneous mammary carcinomas.. PubMed. 19(1). 52–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026